FDA Inspection 740481 — Angelini Pharma, Inc.

Angelini Pharma, Inc. — FEI 3001239013

The FDA completed an inspection of Angelini Pharma, Inc. on August 19, 2011 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 19, 2011
Fiscal Year
2011
Product Type
Devices
Project Area
Compliance: Devices
Location
Atlanta, GA (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
340921 CFR 820.200(d)Service reports